Uroplasty, Inc. (UPI) Posts Strong Q1 Results
Uroplasty, Inc. (NASDAQ: UPI) reported Q1 loss of ($0.06), $0.02 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $4.01 million versus the consensus estimate of $3.58 million.
You May Also Be Interested In
- Netflix, Inc. (NFLX) Misses Q2 EPS by 1c
- Cadence Design Systems (CDNS) Tops Q2 EPS by 1c, Guidance Falls Short; $300M Stock Buyback
- Steel Dynamics, Inc. (STLD) Misses Q2 EPS by 1c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!